Publications

Cardio Ultraefficient nanoParticles for Inhalation of Drug prOducts: when CUPIDO hits the nano-revolution in cardiology.

Catalucci D

Eur Heart J. 42(34):3217-3220. doi: 10.1093/eurheartj/ehab266

Nano-miR-133a Replacement Therapy Blunts Pressure Overload-Induced Heart Failure.

Modica J

Circulation. 2021 Dec 13;144(24):1973-1976. doi: 10.1161/CIRCULATIONAHA.121.055866

Mitochondrial a Kinase Anchor Proteins in Cardiovascular Health and Disease: A Review Article on Behalf of the Working Group on Cellular and Molecular Biology of the Heart of the Italian Society of Cardiology.

Paolillo R

Int J Mol Sci. 2022 Jul 12;23(14)doi: 10.3390/ijms23147691

Antimicrobial peptides for tackling cystic fibrosis related bacterial infections: A review.

Bugli F

Microbiol Res. 2022 Jul 30;263:127152. doi: 10.1016/j.micres.2022.127152

Synthetic recovery of impulse propagation in myocardial infarction via silicon carbide semiconductive nanowires.

Lagonegro P

Nat Commun. 2022 Jan 10;13(1):6. doi: 10.1038/s41467-021-27637-2

Biocompatible antimicrobial colistin loaded calcium phosphate nanoparticles for the counteraction of biofilm formation in cystic fibrosis related infections.

Iafisco M

J Inorg Biochem. 2022 Feb 5;230:111751. doi: 10.1016/j.jinorgbio.2022.111751

Modulation of LTCC Pathways by a Melusin Mimetic Increases Ventricular Contractility During LPS-Induced Cardiomyopathy.

Arina P

Shock. 2022 Mar 9;57(6):318-325. doi: 10.1097/SHK.0000000000001926

Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice.

Condorelli G

Proc Natl Acad Sci U S A. 99(19):12333-8.

MicroRNA-133 controls cardiac hypertrophy.

Carè A

Nat Med. 2007 Apr 29;13(5):613-8.

Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure.

Gallo P

Cardiovasc Res. 2008 Aug 12;80(3):416-24. doi: 10.1093/cvr/cvn215